1 |
Kimura, M., Kobayashi, K., Hata, M., Matsuoka, A., Kitamura, H., and Kimura, Y., Determination of gliclazide in human serum by high-performance liquid chromatography using an anion-exchange resin. J. Chromatogra., 183, 467-473 (1980)
DOI
ScienceOn
|
2 |
Palmer, K. J. and Brogden, R. N., Gliclazide. An update of its pharmacological properties and therapeutic efficacy in noninsulin-dependent diabetes mellitus. Drugs, 46, 92-125 (1993)
DOI
ScienceOn
|
3 |
Davis, T. M. E., Daly, F., Walsh, J. P., Ilett, K. F., Beilby, J. P., Dusci, L. J., and Barrett, P. H. R., Pharmacokinetics and pharmacodynamics of gliclazide in Caucasians and Australian Aborigines with type 2 diabetes. Br. J. Clin. Pharmacol., 49, 223-230 (2000)
DOI
ScienceOn
|
4 |
Glowka, F. K., Hermann, T. W., and Zabel, M., Bioavailablity of gliclazide from some formulation tablets. Int. J. Pharmceut., 172, 71-77 (1998)
DOI
ScienceOn
|
5 |
Campbell, D. B., Adrianessens, P., Hopkins, Y. W., Gordon, B., and Williams, J. R. B., Pharmacokinetics and metabolism of gliclazide: G review. In Gliclazide and the Treatment of Diabetes, Keen H. London (ed). Academic Press and the Royal Society of Medicine, 71-82 (1980)
|
6 |
Shiba, T., Kajinuma, H., Suzuki, K., Hagura, R., and Kawai, A., Serum gliclazide concentration in diabetic patients. Relationship between gliclazide and serum concentration. Diabetes Res. Clin. Prac., 2, 301-306 (1986)
DOI
ScienceOn
|
7 |
Kobayashi, K., Kimura, M., Sakoguchi, T., Kitani, Y., and Hata, M., Influence of blood protein on biomedical analysis. III. Pharmacokinetics and protein binding of gliclazide. J. Pharmacodyn., 4, 436-442 (1981)
|